Healthy pregnancy hub

Regular Strength Aspirin

Last Update: 04 Mar 2025

Welcome to our fact sheet about exposure to regular strength aspirin in pregnancy and while breastfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here.

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is regular strength aspirin?

Aspirin, also known as acetylsalicylic acid, is a non-steroidal inflammatory drug (NSAID) that has been used to treat inflammation, fever, and pain. It has also been used to prevent blood clots. It is available over the counter and by prescription. A single tablet of regular strength aspirin is 325mg. This fact sheet will focus on the use of more than 325mg of aspirin in a 24-hour period.  

Low dose aspirin is sometimes used in pregnancy for different reasons. The pregnancy information for low dose aspirin is different. Consult our fact sheet on low dose aspirin here.

In October 2020, the U.S. Food and Drug Administration (FDA) made a recommendation to avoid the use of NSAIDs, including regular strength aspirin, after 20 weeks of pregnancy, unless your healthcare provider feels it is necessary 

2. What Does Research Say About the Risks During Pregnancy?

I take regular strength aspirin. Can it make it harder for me to get pregnant

It is not known if regular strength aspirin can make it harder to get pregnant. Some studies suggest that using NSAIDs, including regular strength aspirin, may stop an egg from being released from the ovary (ovulation inhibition), which can make it harder to get pregnant.

Does taking regular strength aspirin increase the chance of miscarriage?   

Miscarriage is common and can occur in any pregnancy for many different reasons. An increased chance of miscarriage has been reported with the use of regular strength aspirin, especially with use around the time of conception.    

Does taking regular strength aspirin increase the chance of birth defects?   

Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. It is not known if there is an increased chance for birth defects with the use of regular dose aspirin. Most studies on the use of regular strength aspirin do not show an increased chance of birth defects above the background risk. A few small studies have reported an increased chance of gastroschisis (opening in the stomach wall of the fetus) with early pregnancy use of regular strength aspirin.   

There are some studies that suggest an association between NSAID use, including regular strength aspirin, during the first trimester and a chance for congenital heart defects. However, other studies did not find an increased chance for heart defects when looking specifically at regular strength aspirin use during pregnancy.    

Does taking regular strength aspirin in pregnancy increase the chance of other pregnancy-related problems?  

The use of regular strength aspirin (and/ or other NSAIDs) is not recommended after 20 weeks of pregnancy. There have been reports that NSAID use in the 2nd half of pregnancy might affect the fetal kidneys and the amount of amniotic fluid (fluid that surrounds the fetus in the uterus). If there is not enough amniotic fluid (called oligohydramnios), pregnancy complications such as poor lung development and joint contractures (joints become stiff or unable to move), could happen. Oligohydramnios can also lead to the need to deliver the pregnancy early with induction of labor or C-section. In some cases, oligohydramnios can cause fetal death.  

Use of NSAIDs (including regular strength aspirin) in the 3rd trimester might also cause premature closure of the ductus arteriosus in the fetus. If the ductus arteriosus (an opening between the two major blood vessels leading from the heart) closes before it should, it can cause high blood pressure in the fetal lungs (pulmonary hypertension).   

There can also be an increased chance for other problems, such as bleeding during pregnancy, bleeding after delivery (post-partum hemorrhage), and bleeding in the brain of the newborn with the use of regular strength aspirin in pregnancy. Regular strength aspirin should only be used under a healthcare provider’s supervision, particularly in the 2nd and 3rd trimesters.   

Does taking regular strength aspirin in pregnancy affect future behavior or learning for the child?    

Some studies have shown an increase in newborn bleeding, including bleeding in the brain, from the use of regular strength aspirin during pregnancy. This might affect future brain development.    

3. Breastfeeding while taking regular strength aspirin

Aspirin passes into breastmilk and is broken down by an infant’s body more slowly than in an adult’s body. This means aspirin levels in the infant’s body could build up over time. High doses of aspirin can lower the body’s ability to clot blood (could lead to easier bruising or bleeding). Reye’s syndrome, a rare condition involving brain swelling and liver damage, can be caused by giving aspirin to an infant while they are recovering from a viral infection such as a cold, the flu, or chickenpox. The same risk has not been reported when a baby is exposed to aspirin through breast milk. If you suspect the baby has any symptoms (bleeding or bruising), contact the child’s healthcare provider.

Be sure to talk to your healthcare provider about all your breastfeeding questions. 

4. What About Fathers and Sperm Donors?

If a male takes regular strength aspirin, could it affect fertility (ability to get a partner pregnant) or increase the chance of birth defects?  

Studies have not been done to see if regular strength aspirin could affect a male’s fertility or increase the chance of birth defects above the background risk. In general, exposures that father and sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here

Key Points

  • Aspirin is an NSAID used to treat pain, fever, and inflammation. At a regular dose (more than 325 mg in 24 hours), its use during pregnancy differs from low-dose aspirin.
  • There is little research on its effects during pregnancy. No studies have shown an increased risk of miscarriage, birth defects, preterm birth, or low birth weight. Animal studies have not reported a higher chance of birth defects.
  • Newborns may have withdrawal symptoms if exposed during pregnancy. While not studied specifically for clorazepate, other benzodiazepines have been linked to temporary symptoms in the baby.
  • Clorazepate passes into breast milk and may affect a nursing baby. It stays in the body for a long time and could cause drowsiness or feeding issues. Talk to your healthcare provider to weigh the risks and benefits.
  • Always consult your healthcare provider before making any medication changes.

References

Please click here for references. 

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Émy Roberge
Centre hospitalier universitaire Sainte-Justine
Anne-Sophie Otis
Centre Hospitalier Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University